- Pharmaceutical company Starpharma (SPL) has raised $45 million via an oversubscribed share placement
- All up, 30 million new shares will issued to institutional, sophisticated and professional investors at $1.50 each
- Starpharma will also be undertaking a share purchase plan to raise an additional $5 million
- Eligible shareholders will be able to subscribe for up to $30,000 worth of shares without incurring any brokerage costs
- The company has the right to accept oversubscriptions or scale back applications if it sees fit
- Starpharma has dropped 4.67 per cent and shares are trading for $1.53 each at 11:03 am AEST
